Abstract:Objective: The objective of this study was to compare the outcomes of pharmacomechanical thrombolysis and thrombectomy (PCDT) plus catheter-directed thrombolysis (CDT) vs CDT alone for the treatment of acute iliofemoral deep vein thrombosis (DVT) and summarize the clinical experience, safety outcomes, and short- and long-term efficacy.Methods: We performed a 4-year retrospective, case-control study. A total of 95 consecutive patients with acute symptomatic iliofemoral deep vein thrombosis (DVT) with a symptom duration of <= 7 days involving the iliac and/or common femoral veins underwent endovascular interventions. The patients were divided into two groups according to their clinical indications: PCDT plus CDT vs CDT alone. Statistical analyses were used to compare the clinical characteristics and outcomes between the two groups. Additionally, the patients were followed up for 3 to 36 months after treatment, and the proportions of post-thrombotic syndrome (PTS) and moderate to severe PTS were analyzed using the Kaplan-Meier survival method.Results: A total of 95 consecutive patients were analyzed in this retrospective study, of whom, 51 underwent CDT alone and 44 underwent PCDT plus CDT. Between the two groups, in terms of immediate-term efficacy and safety, significant differences were found in the catheter retention time (60.64 +/- 12.04 hours vs 19.42 +/- 4.04 hours; P < .001), dosages of urokinase required (5.82 +/- 0.81 million units vs 1.80 +/- 0.64 million units; P < .001), the detumescence rate at 24 hours postoperatively (48.46% +/- 8.62% vs 76.79% +/- 7.98%; P = .026), the descent velocity of D-dimer per day (2266.28 +/- 1358.26 mu g/L/D vs 3842.34 +/- 2048.02 mu g/L/D; P = .018), total hospitalization stay (6.2 +/- 1.40 days vs 3.8 +/- 0.70 days; P = .024), number of postoperative angiograms (2.4 +/- 0.80 vs 1.2 +/- 0.30; P = .042), and grade III venous patency (>95% lysis: 54.5% vs 68.6%; P = .047). Furthermore, during the follow-up period, significant differences were found in the incidence of PTS (Villalta scale >= 5 or a venous ulcer: 47.0% vs 27.7%; P = .037), and the incidence proportion of moderate to severe PTS at 12 months (15.7% vs 4.5%; P = .024) and 24 months (35.3% vs 11.4%; P = .016).Conclusions: Compared with CDT alone, in the iliofemoral DVT subgroup with a symptom duration of <= 7 days, PCDT plus CDT could significantly relieve early leg symptoms, shorten the hospitalization stay, reduce bleeding complications, promote long-term venous patency, and decrease the occurrence of PTS and the incidence proportion of moderate to severe PTS. Thus, the short- and long-term outcomes both support the superiority of PCDT plus CDT vs CDT in this subgroup.

Percutaneous Image-Guided Treatment of Pediatric Deep-Vein Occlusions

Interventional Treatment of Pediatric Venous Thromboembolic Disease

A Review of the Effectiveness and Safety of Catheter-Directed Thrombolysis for Venous Thromboembolism

Application of percutaneous transluminal balloon dilatation in patients with catheter-related central vein disease

Percutaneous Transluminal Angioplasty Alleviate Pediatric Postthrombotic Syndrome: A Case Report and Literature Review

Interventional therapy for venous thromboembolism

Endovascular Therapy in Pediatric Stroke: Utilization, Patient Characteristics, and Outcomes

Catheter-Directed Interventions for the Treatment of Lower Extremity Deep Vein Thrombosis

Endovascular treatment for cerebral venous thrombosis: current status, challenges, and opportunities

Endovascular treatment of upper limb phlegmasia cerulea dolens in a hemodialysis patient

Transcatheter recanalization of chronic total occlusion in congenital heart disease: case reports and lessons from percutaneous coronary interventions

Interventional Treatment for Post thrombotic Chronic Venous Obstruction: Progress and Challenges

Endovascular management of proximal lower limb deep venous thrombosis – A prospective study with six-month follow-up

Catheter Directed Thrombolysis for Treatment of Acute Deep Venous Thrombosis of the Lower Extremity of the Effect and Safety Analysis in 116 Cases

Percutaneous reconstruction of chronic total occlusion of brachiocephalic vein using transseptal needle in dialysis-dependent patient

Catheter-Directed Thrombolysis Protocols for Deep Venous Thrombosis of the Lower Extremities-A Systematic Review and Meta-analysis

Comparative Outcomes of Catheter-Directed Thrombolysis Versus AngioJet Pharmacomechanical Catheter-Directed Thrombolysis for Treatment of Acute Iliofemoral Deep Vein Thrombosis.

Ultrasound Guidance for Pediatric Central Venous Catheterization: A Meta-analysis

Successful treatment of a catheter-related right atrial thrombosis with recombinant tissue plasminogen activator and heparin

Comparative Outcomes of Catheter-Directed Thrombolysis versus AngioJet Pharmaco-mechanical Catheter-Directed Thrombolysis for Treatment of Acute Iliofemoral Deep Vein Thrombosis

Novel Challenges and Therapeutic Options for Pulmonary Embolism and Deep Vein Thrombosis